Lifecore Biomedical, Inc. \De\ (LFCR) Shares Outstanding (2010 - 2025)

Lifecore Biomedical, Inc. \De\'s Shares Outstanding (Entity) history runs 16 years deep, the most recent figure standing at $37.0 million for Q2 2025.

• In Q2 2025, Shares Outstanding (Entity) rose 21.15% year-over-year to $37.0 million; the TTM figure through May 2025 stood at $37.0 million (up 21.15% YoY), while the FY2025 annual figure was $37.0 million, up 21.15% from the prior year.
• Shares Outstanding (Entity) for Q2 2025 stood at $37.0 million, roughly flat from $37.0 million in the prior quarter.
• The five-year high for Shares Outstanding (Entity) was $37.0 million in Q2 2025, with the low at $29.3 million in Q1 2021.
• The 5-year median for Shares Outstanding (Entity) is $30.3 million (2023), against an average of $31.2 million.
• The sharpest annual moves came in 2021 and 2024: Shares Outstanding (Entity) grew 0.37% in 2021, then advanced 21.41% in 2024.
• Lifecore Biomedical, Inc. \De\'s Shares Outstanding (Entity) stood at $29.5 million in 2021, then advanced by 2.77% to $30.3 million in 2022, then grew by 0.53% to $30.5 million in 2023, then rose by 21.41% to $37.0 million in 2024, then advanced by 0.12% to $37.0 million in 2025.
• Business Quant data shows LFCR's Shares Outstanding (Entity) at $37.0 million in Q2 2025, $37.0 million in Q1 2025, and $37.0 million in Q4 2024.